Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-02-14
• Last 15 days FTD volume: €0.06 M
• Last 3 months FTD volume: €28.08 M
• Last year FTD volume: €28.08 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€37.38 M	€0.21 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€14.82 M	€52.71 M	🇺🇸 USA
AbbVie ABBV	€43.04 M	€0.20 B	🇺🇸 USA
Illumina ILMN	€18.21 M	€69.96 M	🇺🇸 USA
Biogen BIIB	€42.57 M	€88.22 M	🇺🇸 USA
Pfizer PFE	€24.22 M	€0.33 B	🇺🇸 USA
Johnson & Johnson JNJ	€15.09 M	€0.22 B	🇺🇸 USA
Eli Lilly LLY	€98.85 M	€0.23 B	🇺🇸 USA
Merck MRK	€80.49 M	€0.13 B	🇺🇸 USA